Vanberra Signal

Global Stem cell Technology

Curated by Signal

Developer of blood-derived mesenchymal stem cells for clinical use in animals

Overview

GST is a developer of blood-derived mesenchymal stem cells for clinical use in animals. It has developed stem cell products for horses and dogs. It uses various types of steam cell technology such as peripheral blood-derived, immune invasive properties, allogenic-xenogenic, and many more. Products include GST001 that helps the horse suffers from severe cartilage and bone degeneration, surgical procedures, and others. Other products GST002 which is a major component of tendons in collagen Type I, during the tendon healing phases.

Key facts

Founded
2012
Headquarters
Evergem, Belgium

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Proprietary data solutions for clinical trial optimization and medical expert identification

    Health TechnologyKluisbergen, Belgium
  • Digital telehealth solution for chronic care management

    Health TechnologyLommel, Belgium
  • AI and cloud-based hydration monitoring solutions for healthcare professionals

    Health TechnologyWaterloo, Belgium

About Global Stem cell Technology

What does Global Stem cell Technology do?

GST is a developer of blood-derived mesenchymal stem cells for clinical use in animals.

Where is Global Stem cell Technology headquartered?

Global Stem cell Technology is headquartered in Evergem, Belgium.

When was Global Stem cell Technology founded?

Global Stem cell Technology was founded in 2012.

Which sector is Global Stem cell Technology in?

Global Stem cell Technology operates in Health Technology.

Who are Global Stem cell Technology's competitors?

Companies similar to Global Stem cell Technology include MDCPartners, OptiHealth, and AIDEWA.